Augment Health, Inc. — SEC Form D Filing

Augment Health, Inc. filed an SEC Form D on October 21, 2026, reporting $320K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
October 21, 2026
Amount reported
$320K
Round stage
Seed
Industry
Medical Devices
Website
https://augment.health/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Patients with bladder dysfunction, such as overactive or neurogenic bladder, lack continuous daily monitoring, while traditional clinical urodynamics suffer from scheduling delays and difficulty replicating real-world symptoms.

Solution

Augment Health develops a smart bladder monitor using a catheter attachment worn for 24 to 48 hours to track ambulatory bladder pressure and transmit real-time data to a clinician dashboard for treatment evaluation.

Why now

Miniaturized biosensors and remote patient monitoring tech now enable real-time organ tracking outside traditional hospital settings.

Verdict

This cleared because investors underwrote an inexpensive, milestone-driven hardware wedge addressing the known clinical failure of episodic urodynamics, not because they believed an invasive catheter attachment could scale into a durable remote patient monitoring platform. The check size reflects a translational grant-extension bet: can continuous ambulatory pressure data deliver superior diagnostic yield? The narrative’s durability was capped by the form factor itself, which confines the addressable population to already-catheterized patients and risks fierce clinician pushback on patient compliance and infection liability.

Source: SEC EDGAR Form D filing